Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | PALB2 |
| Variant | K142Nfs*35 |
| Impact List | frameshift |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | PALB2 K142Nfs*35 indicates a shift in the reading frame starting at amino acid 142 and terminating 35 residues downstream causing a premature truncation of the 1186 amino acid Palb2 protein (UniProt.org). K142Nfs*35 has not been characterized however, due to the effects of other truncation mutations downstream of K142 (PMID: 31636395, PMID: 31757951), is predicted to lead to a loss of Palb2 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
PALB2 mutant PALB2 inact mut PALB2 K142Nfs*35 |
| Transcript | NM_024675.4 |
| gDNA | chr16:g.23636120delC |
| cDNA | c.426delG |
| Protein | p.K142Nfs*35 |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_011545946.2 | chr16:g.23636127_23636128insGGGGGGGGGGGGGGGGGGTTGT | c.425_426insCAACCCCCCCCCCCCCCCCCCA | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407308.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407302.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407297.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_024675.4 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407301.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407299.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| XM_017023672.2 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407307.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407305.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407304.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| XM_011545947.2 | chr16:g.23636127_23636128insGGGGGGGGGGGGGGGGGGTTGT | c.425_426insCAACCCCCCCCCCCCCCCCCCA | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| XM_017023673.2 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407300.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407306.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407298.1 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| XM_011545948.2 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407309.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_024675.3 | chr16:g.23636120delC | c.426delG | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407311.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| XM_017023671.1 | chr16:g.23636127_23636128insGGGGGGGGGGGGGGGGGGTTGT | c.425_426insCAACCCCCCCCCCCCCCCCCCA | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| NM_001407310.1 | chr16:g.(23635130_23635237) | c.(424_531) | p.K142Nfs*35 | RefSeq | GRCh38/hg38 |
| Molecular Profile | Protein Effect | Treatment Approaches |
|---|---|---|
| PALB2 K142Nfs*35 | loss of function - predicted | PARP Inhibitor (Pan) |